← Back to Search

Experimental for Opioid Use Disorder (ISTOP Trial)

N/A
Waitlist Available
Led By Joji Suzuki, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks after baseline
Awards & highlights

Summary

This trial will test whether coaching can help people stick with treatment and stay off opioids after being released from the hospital.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment Retention
Secondary study objectives
Days to Hospital Readmission
Days to Treatment Discontinuation
Readmissions

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Subjects randomized to the experimental arm will be assigned to a recovery coach.In addition to being linked to a community buprenorphine or methadone treatment program, the recovery coach will work to meet weekly with the subject following discharge from the hospital to provide support.
Group II: ControlActive Control1 Intervention
Subjects randomized to the control arm will receive treatment as usual. This means subjects are linked to ongoing outpatient treatment with buprenorphine or methadone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Recovery coach
2019
N/A
~30

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,628 Previous Clinical Trials
11,474,611 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,503 Previous Clinical Trials
2,625,554 Total Patients Enrolled
Joji Suzuki, MDPrincipal Investigator - Brigham and Women's Hospital
Brigham & Women's Faulkner Hospital, Brigham & Women's Hospital
Boston University School Of Medicine (Medical School)
Boston Medical Center (Residency)
1 Previous Clinical Trials
~4 spots leftby Sep 2025